DSS Inc. Common Stock (DSS)

FairStock Score: 29/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for a durable business bought at a sensible price. DSS offers neither comfort nor a margin of safety. It operates in packaging, biotechnology, commercial lending, securities, and direct marketing—a grab bag that suggests no clear competitive moat. The numbers confirm it: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $3.6M and net loss $4.8M, versus revenue $5.3M and net loss $2.2M in fiscal Q2 2025. For FY2025 ended 2025-12-31, revenue was $20.8M and net loss $23.9M; FY2024 was $19.1M revenue and $46.9M net loss, so the loss narrowed but remains severe. Free cash flow is negative—$-11.0M trailing—and the FairStock FCF yield is -177.5%, so the company consumes cash. Balance-sheet risk is high: D/E 5.10, FairStock Altman Z -7.68, FairStock ROE -172.20%, and FairStock ROCE -12.80%. The FairStock Piotroski F-Score is 4/9 and the FairStock Score is 29/100. At $0.62 on 2026-10-13, market cap is $6.2M and the FairStock P/B is 1.53; filed diluted EPS was -$6.63 in FY2024 and -$8.20 in FY2023, so there is no earnings support. The 52-week range is $0.36-$1.86, showing how volatile the quote can be. A low price is not the same as cheap. Without a path to positive earnings and cash flow, book value and hope are doing the work. I would need evidence of durable profitability, lower leverage, and less cash burn before calling this a value opportunity.

In plain English: DSS Inc. is a small company that runs several businesses, including packaging, health products, lending, investing, and direct marketing. It has lost money for years, sales fell in the latest quarter from a year earlier, and it is burning cash. At $0.62, the price may look low, but the weak finances and ongoing losses mean it does not look like a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer